Nothing Special   »   [go: up one dir, main page]

IE902195L - Magnetic protein conjugates - Google Patents

Magnetic protein conjugates

Info

Publication number
IE902195L
IE902195L IE902195A IE219590A IE902195L IE 902195 L IE902195 L IE 902195L IE 902195 A IE902195 A IE 902195A IE 219590 A IE219590 A IE 219590A IE 902195 L IE902195 L IE 902195L
Authority
IE
Ireland
Prior art keywords
protein conjugates
cells
magnetic protein
removal
diagnostic
Prior art date
Application number
IE902195A
Other versions
IE902195A1 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IE902195L publication Critical patent/IE902195L/en
Publication of IE902195A1 publication Critical patent/IE902195A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
    • G01N2446/90—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids characterised by small molecule linker used to couple immunoreagents to magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Food Science & Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to magnetic protein conjugates of the general formula I M-NH-CO-(CH2)n-S-SP I with n = 1-6, preferably with n = 2 or 3, in which M is a dispersible, magnetically reacting material or particle which carries amino groups, and P is a protein, to a method for making them and to their use for the specific removal of cells or soluble antigens, receptors, substrates, cofactors or carbohydrate determinants from aqueous salt solutions or body fluids or as part of a diagnostic method or as diagnostic aid, preferably for the removal of cells, preferably for bone marrow depletion or for HLA typing. [EP0403960A2]
IE219590A 1989-06-19 1990-06-18 Magnetic protein conjugates, a process for the preparation¹thereof and the use thereof IE902195A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3919923A DE3919923A1 (en) 1989-06-19 1989-06-19 MAGNETIC PROTEIN CONJUGATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Publications (2)

Publication Number Publication Date
IE902195L true IE902195L (en) 1990-12-19
IE902195A1 IE902195A1 (en) 1991-01-02

Family

ID=6383013

Family Applications (1)

Application Number Title Priority Date Filing Date
IE219590A IE902195A1 (en) 1989-06-19 1990-06-18 Magnetic protein conjugates, a process for the preparation¹thereof and the use thereof

Country Status (7)

Country Link
EP (1) EP0403960A2 (en)
JP (1) JPH0341098A (en)
AU (1) AU5717990A (en)
CA (1) CA2019217A1 (en)
DE (1) DE3919923A1 (en)
IE (1) IE902195A1 (en)
PT (1) PT94399A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4033714C3 (en) * 1990-10-24 1995-09-07 Brahms Diagnostica Gmbh New hapten analysis based on the principle of an antigen-antibody reaction
GB9105031D0 (en) * 1991-03-09 1991-04-24 Fisons Plc Processing analytical reagents
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
NO180658C (en) 1994-03-10 1997-05-21 Oeystein Fodstad Method and Device for Detecting Specific Target Cells in Specialized or Mixed Cell Populations and Solutions Containing Mixed Cell Populations
NO961031D0 (en) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Procedure for killing unwanted target cells
KR20030047499A (en) * 2001-12-11 2003-06-18 김근상 Multi-terminal plug and jack

Also Published As

Publication number Publication date
DE3919923A1 (en) 1990-12-20
AU5717990A (en) 1990-12-20
IE902195A1 (en) 1991-01-02
EP0403960A2 (en) 1990-12-27
CA2019217A1 (en) 1990-12-19
PT94399A (en) 1991-02-08
JPH0341098A (en) 1991-02-21

Similar Documents

Publication Publication Date Title
AU639867B2 (en) Magnetic protein conjugates, a process for the preparation thereof and the use thereof
HK101395A (en) Assay of a body fluid for measuring bone resorptioon
EP0224934A3 (en) Contrast agent, process for its preparation and its use for ultrasonic imaging
NZ213680A (en) Monoclonal antibody to cyclosporin and process for its production
GR3006727T3 (en)
IE891182L (en) Compositions, diagnostic kit and method for rapid detection¹of antibodies
IL137766A0 (en) Strategically modified hepatitis b core proteins and their derivatives
EP0401199A3 (en) Method for the preparation of biological implant material
PT969873E (en) MULTIPLE ANTIGEN GLYCOPEPTIDE CARBON HYDRATE, VACCINE COATING THE SAME AND ITS USE
CA2156857A1 (en) Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
IE902195L (en) Magnetic protein conjugates
EP0388356A3 (en) Ultraviolet absorbing lenses and methods of making the same
YU49189A (en) Magnetic proteinic conjugates, process for preparing and use thereof
ZA875176B (en) Immunotozins,process for their preparation and pharmaceutical compositions in which they are present
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
AU6823390A (en) An agent for improving the recovery of annexins
DE3370026D1 (en) Biologically active conjugates and their preparation and use
EP0096932A3 (en) Process for making a lyophilized product for use in skeletal imaging
EP0363040A3 (en) Herbicides
GR3035226T3 (en) Immunoenzymatic conjugate, preparation method therefor and uses thereof
GB8906708D0 (en) Improvements relating to the radiolabelling of proteins
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
JPS6470490A (en) Mitomycins and production thereof
JPS6445795A (en) Calcium phosphate compact and production thereof
LeGeros et al. BIOGLASS® SURFACE REACTIVITY: FROM IN VITRO TO IN VIVO